- Federal agenciesAllows federal authorities to regulate and seize a wide range of fentanyl analogs without listing each chemical individ…
- Potential benefitEases prosecution of supply and distribution of novel fentanyl variants by covering structurally related substances.
- Potential benefitMay reduce the availability of designer fentanyls on illicit markets, potentially lowering some overdose risks.
Federal Initiative to Guarantee Health by Targeting Fentanyl Act
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for co…
This bill amends the Controlled Substances Act to add a broad category of "fentanyl-related substances" to Schedule I, defining the category by several classes of structural modifications. It also specifies that any mandatory minimum prison terms that would otherwise apply under a referenced penalty provision do not apply to substances described by the new fentanyl-related substances listing.
All agree on need to combat fentanyl, differ on sentencing and scope
Relative to its intended legislative type, this bill is a direct and specific statutory amendment that clearly defines the operative legal change (adding a broad class of fentanyl-related substances to Schedule I and altering an applicable minimum sentence exemption).
This bill amends the Controlled Substances Act to add a broad category of "fentanyl-related substances" to Schedule I, defining the category by several classes of structural modifications.
It also specifies that any mandatory minimum prison terms that would otherwise apply under a referenced penalty provision do not apply to substances described by the new fentanyl-related substances listing.
Narrow subject improves prospects, but broad structural scheduling, legal vagueness concerns, and Senate hurdles reduce overall likelihood.
Relative to its intended legislative type, this bill is a direct and specific statutory amendment that clearly defines the operative legal change (adding a broad class of fentanyl-related substances to Schedule I and altering an applicable minimum sentence exemption). It includes a relatively detailed definition mechanism but lacks implementation guidance, fiscal acknowledgment, edge-case safeguards, and accountability provisions.
All agree on need to combat fentanyl, differ on sentencing and scope
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenThe chemical definition is broad and could unintentionally encompass benign or novel research compounds.
- Potential burdenSchedule I designation imposes significant regulatory barriers that can hinder legitimate scientific and medical resear…
- Federal agenciesBroad federal control may increase compliance costs for laboratories, manufacturers, and testing facilities.
Why the argument around this bill splits.
All agree on need to combat fentanyl, differ on sentencing and scope
Generally supports measures that reduce overdose deaths and target illicit fentanyl, but worries the broad chemical definition could criminalize research, harm public-health approaches, and enable aggressive policing.
Praises removal of mandatory minimums but seeks explicit protections for treatment, harm reduction, and scientific research.
Sees practical benefits in a clean legal tool against rapidly changing fentanyl analogs and likes the removal of mandatory minimums as a pragmatic balance.
Wants clearer statutory language about scope, research exemptions, and implementation to avoid unintended consequences.
Supports stronger legal tools against fentanyl trafficking and the scheduling of analogs, viewing this as a needed law-and-order measure.
However, objects to removing mandatory minimums, believing stricter penalties deter traffickers; may seek restoration of tougher sentencing.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Narrow subject improves prospects, but broad structural scheduling, legal vagueness concerns, and Senate hurdles reduce overall likelihood.
- Administrative implementation and DEA rulemaking timeline
- Potential legal challenges on vagueness and scientific definition
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
All agree on need to combat fentanyl, differ on sentencing and scope
Narrow subject improves prospects, but broad structural scheduling, legal vagueness concerns, and Senate hurdles reduce overall likelihood.
Relative to its intended legislative type, this bill is a direct and specific statutory amendment that clearly defines the operative legal change (adding a broad class of fentanyl-related substances to Schedule I and al…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.